PMDA — authorised 22 January 2021
- Marketing authorisation holder: Kyorin Pharmaceutical Co Ltd
- Status: approved
🇯🇵 Rimso-50 in Japan
PMDA authorised Rimso-50 on 22 January 2021
Marketing authorisation
Rimso-50 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in Japan
Frequently asked questions
Is Rimso-50 approved in Japan?
Yes. PMDA authorised it on 22 January 2021.
Who is the marketing authorisation holder for Rimso-50 in Japan?
Kyorin Pharmaceutical Co Ltd holds the Japanese marketing authorisation.